In the letter, Somani said the samples of four made-in-India cough syrups linked to the deaths of 66 children in Gambia, which were tested in a government laboratory in the country, were found to be complying with specifications.The DCGI had said that India has been committed to rigorous monitoring and oversight to ensure that the highest standards of manufacture are maintained in quality control of drugs and cosmetics.
New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has initiated a probe in connection with the death of 18 children in Uzbekistan allegedly linked to a cough syrup manufactured by an Indian firm.
The Centre today said it is in touch with Uzbekistan after it alleged 18 children in the country have died after taking an India-manufactured cough syrup. An investigation is in progress and the manufacturing of the cough syrup has been stopped.
Cough syrup-linked deaths in Uzbekistan: The Health Ministry of Uzbekistan earlier claimed that the 18 children had consumed cough syrup, Doc-1 Max , manufactured by Noida-based Marion Biotech.